Acute mountain sickness impact among travelers to cusco, peru

Journal of Travel Medicine

Volumn 19, Issue 4, 2012, Pages 220-225

  Salazar, Hugo ^a   Swanson, Jessica ^a   Mozo, Karen ^b   Clinton White Jr , A ^a   Cabada, Miguel M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSIDAD NACIONAL DE SAN ANTONIO ABAD DEL CUSCO   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; PLANT MEDICINAL PRODUCT;

ACUTE DISEASE; ACUTE MOUNTAIN SICKNESS; ADULT; AGED; ALTITUDE DISEASE; ARTICLE; COCA; FEMALE; HUMAN; LAKE LOUISE CLINICAL SCORE; MAJOR CLINICAL STUDY; MALE; PERU; SCORING SYSTEM; TOURISM; TRAVEL;

ACETAZOLAMIDE; ACUTE DISEASE; ADOLESCENT; ADULT; ALTITUDE SICKNESS; COCA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERU; PHYTOTHERAPY; QUESTIONNAIRES; TRAVEL; YOUNG ADULT;

EID: 84863719681     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2012.00606.x     Document Type: Article

References (32)

1. Data.un.org [Internet] Statisticsâ-Arrivals of non-resident tourist/visitors, departures and tourism expenditures in the country and other countries. World Tourism Organization Available from: (Cited 2011 Jun 1).
2. Gallagher SA, Hackett PH., High-altitude illness. Emerg Med Clin North Am 2004; 22: 329-355.
3. Dirceturcusco.gob.pe [Internet] Estadisticaâ-Region 2009: arribos de turistas extranjeros [website in Spanish] Available from: (Cited 2011 Jun 1).
4. Cabada MM, Maldonado F, Mozo K, et al., Self-reported health problems among travelers visiting Cusco: a Peruvian airport survey. Travel Med Infect Dis 2009; 7: 25-29.
5. Leshem E, Pandey P, Shlim DR, et al., Clinical features of patients with severe altitude illness in Nepal. J Travel Med 2008; 15: 315-322.
6. Gaillard S, Dellasanta P, Loutan L, Kayser B., Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt Med Biol 2004; 5: 410-419.
7. Vardy J, Vardy J, Judge K., Can knowledge protect against acute mountain sickness? J Pub Health (Oxf.) 2005; 27: 366-370.
8. Cabada MM, Maldonado F, Quispe W, et al., Pretravel health advice among international travelers visiting Cuzco, Peru. J Travel Med 2005; 12: 61-5.
9. Bauer I., Travel health advice as recalled by 552 tourists to Peru. J Travel Med 2002; 9: 293-296.
10. Roach RC, Bartsch P, Hackett PH, Oelz O., The Lake Louise Acute Mountain Sickness scoring system. In:, Sutton JR, Houston CS., Coates G, eds. Hypoxia and molecular medicine. Burlington, VT: Queen City Printers, 1993: 272-274.
11. Vargas M, Osorio J, Jiménez D, et al., Acute mountain sickness at 3,500 and 4,250 m. A study of symptom, incidence and severity (in Spanish). Rev Med Chil 2001; 129: 166-172.
12. Moraga FA, Osorio JD, Vargas ME., Acute mountain sickness in tourists with children at Lake Chungará (4,400 m) in northern Chile. Wilderness Environ Med 2002; 13: 31-35.
13. Moraga FA, Pedreros CP, RodrÄguez CE., Acute mountain sickness in children and their parents after rapid ascent to 3,500 m (Putre, Chile). Wilderness Environ Med 2008; 19: 287-292.
14. Honigman B, Theis MK, Koziol-McLain J, et al., Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993; 118: 587-592.
15. Provost S, Soto JC., Predictors of pretravel consultation in tourist from Quebec (Canada). J Travel Med 2001; 8: 66-75.
16. Cabada MM, Maldonado F, Mozo K, et al., Pre-travel preparation for Cusco, Peru: a comparison between European and North American travelers. J Travel Med 2010; 17: 382-386.
17. Leggat PA., Sources of health advice given to travelers. J Travel Med 2000; 7: 85-88.
18. Farquharson L, Noble LM, Barker C, Behrens RH., Health beliefs and communication in the travel clinic consultation as predictors of adherence to malaria chemoprophylaxis. Br J Health Psychol 2004; 9: 201-217.
19. Kilner T, Mukerji S., Acute mountain sickness prophylaxis: knowledge, attitudes, and behavior in the Everest region of Nepal. Travel Med Infect Dis 2010; 8: 395-400.
20. Luks AM, McIntosh SE, Grissom CK, et al., Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 2010; 21: 146-155.
21. Spielvogel H, Rodriguez A, Sempore B, et al., Body fluid homeostasis and cardiovascular adjustments during submaximal exercise: influence of chewing coca leaves. Eur J Appl Physiol Occup Physiol 1997; 75: 400-406.
22. Glauser J, Queen JR., An overview of non-cardiac cocaine toxicity. J Emerg Med 2007; 32: 181-186.
23. O'Leary ME, Hancox JC., Role of voltage-gated sodium, potassium, and calcium channels in the development of cocaine-associated cardiac arrhythmias. Br J Clin Pharmacol 2010; 69: 427-442.
24. Jackson GF, Saady JJ, Poklis A., Urinary excretion of benzoylecgonine following ingestion of Health Inca Tea. Forensic Sci Int 1991; 49: 57-64.
25. Mazor SS, Mycyk MB, Wills BK, et al., Coca tea consumption causes positive urine cocaine assay. Eur J Emerg Med 2006; 13: 340-341.
26. Floren AE, Small JW., Mate de coca equals cocaine. J Occup Med 1993; 35: 95-96.
27. Lyon RM, Wiggins CM., Expedition medicineâ-the risk for illness and injury. Wilderness Environ Med 2010; 21: 318-324.
28. Anderson SR, Johnson CJ., Expedition health and safety: a risk assessment. J R Soc Med 2000; 93: 557-562.
29. Hart O., Severe high-altitude cerebral edema on the Inca Trail. J Travel Med 2004; 11: 64-65.
30. Mieske K, Flaherty G, O'Brien T., Journeys to high altitudeâ-risks and recommendations for travelers with pre-existing medical conditions. J Travel Med 2010; 17: 48-62.
31. Ri-Li G, Chase PJ, Witkowski S, et al., Obesity: associations with acute mountain sickness. Ann Intern Med 2003; 139: 253-257.
32. Paz A, Steinfeld I, Potasman I., Are we doing our best to educate travelers about the risks of acute mountain sickness? An on-site prospective study in the Himalayas. J Travel Med 2007; 14: 168-172.